https://newsletter.glp1studio.com/p/a-new-challenger-drug-lines-up-againstGLP-1 Studioen2026-09-27T17:00:00+00:00A new challenger drug lines up against semaglutide in humanshttps://newsletter.glp1studio.com/p/orforglipron-weight-loss-holds-steadyGLP-1 Studioen2026-09-27T17:00:00+00:00Orforglipron weight loss holds steady through menopause stages